東雅惠 – NYCU

東雅惠副教授

YAA-HUI DONG

電子郵件 : ydong3@nycu.edu.tw

連絡電話 : 02-28267000#67986

教師個人CV

學歷

2008 ~2012 臺大流行病學與預防醫學研究所博士
1999 ~2001 臺大藥學研究所醫院藥學組碩士
1994 ~1998 臺大藥學系學士

經歷

國立陽明大學藥學系副教授(2021-迄今)
國立陽明大學藥學系助理教授(2016-2021)
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital and Harvard Medical School, US
Post-doctoral Research Fellow(2014-2016)
國泰綜合醫院汐止分院藥劑科諮詢藥師 (兼職)(2013-2014)
臺灣大學健康資料研究中心博士後研究員(2012-2013)
國泰綜合醫院藥劑科藥師(2003-2008)
中華景康藥學基金會研究助理(2003)
和信治癌中心醫院藥劑科藥師(2002-2003)
臺大臨床藥學研究所助教(2001-2002)
馬偕紀念醫院藥劑科藥師(1998-1999)

學術專長

藥物流行病學、系統回顧與統合分析、臨床藥學

代表著作

(*corresponding author, #equal contribution)

Dong YH, Chang CH*, Lin JW*, Yang WS, Wu LC, Toh S (2022, May). Comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists versus sodium glucose cotransporter 2 inhibitors in patients with type 2 diabetes: a population-based cohort study. Diabetes Obes Metab. 2022 May 1. doi: 10.1111/dom.14741. Online ahead of print.
Dong YH*, Chang CH*, Wang JL, Wu LC, Lin JW, Toh S (2020, Dec). Association of infections and use of fluoroquinolones with the risk of aortic aneurysm or aortic dissection. JAMA Intern Med. 2020;180:1587-1595.
Dong YH, Jin Y, Tsacogianis TN, He M, Hsieh PH, Gagne JJ* (2018, Mar). Use of olmesartan and enteropathy outcomes: a multi-database study. Aliment Pharmacol Ther. 2018;47:792-800.
Dong YH#, Chang CH#, Wu FL, Shen LJ, Calverley PMA, Löfdahl CG, Lai MS*, Mahler DA (2014, Jun). Use of inhaled corticosteroids in patients with chronic obstructive pulmonary disease and the risk of tuberculosis and influenza: a systematic review and meta-analysis of randomized controlled trials. Chest. 2014;145:1286-1297.
Dong YH, Lin HH, Shau WY, Wu YC, Chang CH*, Lai MS* (2013, Jan). Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomized controlled trials. Thorax. 2013;68:48-56.